Fornix-based trabeculectomy with Wise's suture technique in Chinese patients

Ophthalmology. 2000 Dec;107(12):2310-3. doi: 10.1016/s0161-6420(00)00460-7.

Abstract

Objective: To assess the safety and efficacy of fornix-based trabeculectomy with Wise's suture technique in Chinese subjects.

Design: A retrospective noncomparative case series.

Participants: Forty-eight eyes of 44 Chinese subjects that underwent fornix-based trabeculectomy combined with intraoperative 0.4 mg/ml mitomycin-C for 3 to 5 minutes were studied.

Intervention: Conjunctival wound closure of all eyes was with the Wise's technique using 9-0 nylon suture to prevent leakage at the corneolimbal interface.

Main outcome measures: The success rate, with or without antiglaucoma medication, the complication rate, and the longevity of the drainage blebs were analyzed.

Results: At a mean follow-up period of 21.8 +/- 4.5 months, 75% (36 eyes) had postoperative intraocular pressure of 21 mmHg or less. Of these, 23 eyes (47.9%) required no antiglaucoma medication, 7 eyes (14.6%) required one medication, 3 eyes (6.3%) required two medications, and 3 eyes (6.3%) required three medications. Ten eyes (21%) had early wound leak. Two eyes (4.2%) required surgical repair. Two eyes (4%) had hypotonous maculopathy. No other major complications were encountered.

Conclusions: Fornix-based trabeculectomy with adjunctive mitomycin-C using Wise's suture technique appears to be both safe and effective in Chinese subjects.

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Asian Continental Ancestry Group*
  • Chemotherapy, Adjuvant
  • Female
  • Follow-Up Studies
  • Glaucoma / drug therapy
  • Glaucoma / ethnology
  • Glaucoma / surgery*
  • Hong Kong / epidemiology
  • Humans
  • Intraocular Pressure
  • Male
  • Middle Aged
  • Mitomycin / therapeutic use
  • Postoperative Complications
  • Retrospective Studies
  • Safety
  • Suture Techniques*
  • Trabeculectomy / methods*
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Mitomycin